Assessment of Heart and Liver Iron Overload in Thalassemia Major Patients Using T2* Magnetic Resonance Imaging
- 15 June 2016
- journal article
- research article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 33 (2) , 228-234
Abstract
Accumulation of excess iron in heart can lead to cardiac dysfunction, which is the most common cause of death in thalassemia major patients. Biopsy is an invasive procedure and therefore not an ideal option to assess iron load. However, standard/usual non-invasive methods, such as ferritin measurement, have some limitations and the results show poor correlations with iron load. Magnetic Response Imaging (MRI-T2*), as a non-invasive and reliable method for iron load assessment in organs such as liver and heart, can be suggested as a favorable alternative. This cross-sectional study was implemented in Thalassemia and Hemophilia Clinic Center (Sarvar) affiliated with Mashhad University of Medical Sciences, Mashhad, Iran, from 2012 to 2013. After the approval of the research protocol by the local ethic committee, laboratory tests, including CBC and serum ferritin, were carried out, and echocardiography and heart and liver MRI-T2* were performed. All statistical analysis was done through SPSS software (version 11.5), using independent sample t test and Pearson’s correlation coefficient test. A P value ≤0.05 was considered to be significant. 88 patients with the mean (±SD) age of 21.2 (±5.6) years, (range 11–37 years) were observed. Iron load was assessed using MRI-T2* with the following results: Out of 88 patients, 48.9 % had mild to severe cardiac siderosis, and 75.2 % had mild to severe liver siderosis. We demonstrated a correlation between liver MRI-T2* and serum ferritin, and heart MRI-T2* and ejection fraction. However, no correlation between liver and heart MRI-T2* was observed. Heart and liver siderosis is a common and serious problem in thalassemia major patients, and MRI-T2* as a sensitive and non-invasive technique can be used for early/timely detection of siderosis and good therapeutic monitoring in these patients.Keywords
Funding Information
- faculty of medicine, Mashhad University of Medical Sciences, Mashhad, Iran (2681)
This publication has 21 references indexed in Scilit:
- CLSI-based transference of the CALIPER database of pediatric reference intervals from Abbott to Beckman, Ortho, Roche and Siemens Clinical Chemistry Assays: Direct validation using reference samples from the CALIPER cohortClinical Biochemistry, 2013
- International survey of T2* cardiovascular magnetic resonance in -thalassemia majorHaematologica, 2013
- Screening of Hemoglobin Disorders in Referral Cases to the Hospital’s Laboratory in Northeast IranInternational Journal of Hematology and Oncology, 2013
- Measurement of liver iron overload: Noninvasive calibration of MRI-R2* by magnetic iron detector susceptometerMagnetic Resonance in Medicine, 2011
- Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemiasEuropean Journal of Internal Medicine, 2011
- Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia MajorCirculation, 2009
- Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiproneHaematologica, 2009
- Practical implications of liver and heart iron load assessment by T2*‐MRI in children and adults with transfusion‐dependent anemiasAmerican Journal of Hematology, 2008
- Long Term Comparative Studies in Thalassemia Patients Treated with Deferoxamine or a Deferoxamine/Deferiprone Combination. Identification of Effective Chelation Therapy ProtocolsHemoglobin, 2008
- Thalassemia in IranJournal of Pediatric Hematology/Oncology, 2007